Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Sky One Puts Eight New Tests in Clinical Trials

publication date: Jul 27, 2007
An Expanding Pipeline -- China Sky One Medical (OTC BB: CSKI.OB) will begin clinical tests of eight new diagnostic products next month. The tests, which will begin in August, are slated for completion before the end of this year. The products include: Rapid diagnosis kit for urine microalbumin; Urine test for determining the ovulation cycle; Rapid detection of prealbumin; Rapid detection kit for APO B; Rapid detection kit for APO A1; Rapid detection kit for magnesium ion; Semi-quantitative test for uterine cancer; and Semi-quantitative test of calcium ion. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital